Adaptalogix helps gene therapy companies to examine their technology infrastructures, develop the appropriate SOPs and ensure they are prepared when the FDA approvals come through.
With NetSuite as its foundation, AdaptaLogix’s SuiteSuccess for Pharma gives pharmaceutical companies everything they need to build out successful, end-to-end supply chains for their promising new drugs.
Pre-revenue pharmaceutical companies entering Phase II, IIb and III clinical trials experience massive change to their business in a period of months or years that for companies in other industries can take decades.
Phase 2b and Phase 3 pharma and biotech companies see extraordinary changes in their business as they progress through regulatory approval. Employee growth, SEC regulations and the need to make key decisions on manufacturing strategy…
In the decades James Neal spent in systems implementation and consulting for pharmaceuticals, he identified a gap at a critical point in the lifecycle of clinical, pre-revenue pharmaceutical companies.
Within a year, a pre-revenue pharmaceutical company can experience tremendous growth as they enter phase 2b and phase 3 clinical trials, going from six employees to 60. This growth accelerates further as they add hundreds of employees and exit phase 3 clinical trials...